Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07129460) titled 'Efficacy and Safety of Berberine for Gastric Intestinal Metaplasia: a Prospective, Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial' on Aug. 12.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).

Primary Sponsor: Xijing Hospital of Digestive Diseases

Condition: Gastric Intestinal Metaplasia

Intervention: Drug: Berberine hydrochloride

Recruitment Status: Not recruiting

Phase: Phase 4

Date of First Enrollment: October 1, 2025

Target Sample Size: 204

To kn...